The first HCA Healthcare trade was made in Q4 2012.
Since then David Tepper bought shares thirteen more times and sold shares on twenty occasions. The investor sold all their shares in Q1 2024 and doesn't own any shares in HCA Healthcare anymore.
Avg closing price
Price range
Sold -117 Thousand shares
Q1 2024
Avg closing price
$305.59
Price range
$272.08
-
$333.53
New holding (+117 Thousand shares)
Q4 2023
Avg closing price
$247.16
Price range
$221.81
-
$275.85
Sold -143 Thousand shares
Q2 2023
Avg closing price
$278.02
Price range
$264.09
-
$303.48
Sold 21.9% shares (-40 Thousand shares)
Q1 2023
Avg closing price
$254.01
Price range
$243.21
-
$263.81
Increased shares by 143.3% (+108 Thousand shares)
Q4 2022
Avg closing price
$223.97
Price range
$193.26
-
$244.70
New holding (+75 Thousand shares)
Q2 2022
Avg closing price
$214.83
Price range
$168.06
-
$275.16
Sold -387 Thousand shares
Q4 2021
Avg closing price
$244.70
Price range
$225.59
-
$260.00
Sold 4.4% shares (-18 Thousand shares)
Q3 2021
Avg closing price
$244.48
Price range
$211.83
-
$261.64
Sold 57.4% shares (-545 Thousand shares)
Q2 2021
Avg closing price
$203.81
Price range
$186.15
-
$215.87
Sold 5.0% shares (-50 Thousand shares)
Q1 2021
Avg closing price
$176.44
Price range
$157.02
-
$191.82
Increased shares by 7.0% (+65 Thousand shares)
Q4 2020
Avg closing price
$146.22
Price range
$123.94
-
$165.86
Sold 11.0% shares (-115 Thousand shares)
Q3 2020
Avg closing price
$123.78
Price range
$94.34
-
$138.17
Increased shares by 268.4% (+765 Thousand shares)
Q2 2020
Avg closing price
$103.96
Price range
$81.83
-
$118.04
New holding (+285 Thousand shares)
Q1 2020
Avg closing price
$129.47
Price range
$68.13
-
$151.04
Sold -283 Thousand shares
Q2 2018
Avg closing price
$101.18
Price range
$95.32
-
$107.79
Sold 48.8% shares (-270 Thousand shares)
Q1 2018
Avg closing price
$97.03
Price range
$84.96
-
$103.90
Increased shares by 201.0% (+369 Thousand shares)
Q4 2017
Avg closing price
$80.34
Price range
$74.22
-
$89.69
Increased shares by 9.5% (+16 Thousand shares)
Q3 2017